Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 6/20 | 0.58 |
| ▸ | CHRM1 | P11229 | 5/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.58 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.58 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.58 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.58 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.58 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.58 |
| ▸ | HRH1 | P35367 | 1/20 | 0.58 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.58 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.58 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.58 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.58 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | HTR1A | P08908 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21483711 | 1.00 | CHRM2 (0.58) | CHRM2CHRM1CYP2D6KCNH2CHRM3 | |
| SCHEMBL1847210 | 0.98 | CHRM2 (0.60) | CHRM2CHRM1CYP2D6KCNH2CHRM3 | |
| SCHEMBL6700758 | 0.98 | CHRM2 (0.60) | CHRM2CHRM1CYP2D6KCNH2CHRM3 | |
| SCHEMBL6704158 | 0.98 | CHRM2 (0.60) | CHRM2CHRM1CYP2D6KCNH2CHRM3 | |
| SCHEMBL12441787 | 0.81 | CHRM2 (0.66) | CHRM2CHRM1CYP2D6KCNH2CHRM3 | |
| SCHEMBL2933098 | 0.81 | CHRM2 (0.66) | CHRM2CHRM1CYP2D6KCNH2CHRM3 | |
| SCHEMBL11161473 | 0.80 | KEAP1 (0.57) | CHRM2CHRM1CYP2D6KCNH2CHRM3 | |
| SCHEMBL2762931 | 0.79 | CHRM2 (0.56) | CHRM2CHRM1CYP2D6KCNH2CHRM3 | |
| SCHEMBL10392382 | 0.79 | CHRM2 (0.64) | CHRM2CHRM1CYP2D6KCNH2CHRM3 | |
| SCHEMBL10370745 | 0.79 | CHRM2 (0.58) | CHRM2CHRM1CYP2D6KCNH2CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116046945-B | Method for detecting related substances of penehyclidine hydrochloride injection by high performance liquid chromatography | 上海旭东海普药业有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-116046945-A | Method for detecting related substances of penehyclidine hydrochloride injection by high performance liquid chromatography | 上海旭东海普药业有限公司 | 2023-05-02 | — | — | CN | claimed |
| CN-104090037-B | A kind of detection method of catabolite of amyl ethyl quin ether hydrochloride | CHENGDU LISITE PHARMACEUTICAL CO., LTD. (CN) | 2015-12-30 | — | — | CN | claimed |
| CN-104090037-A | Detection method of degradation product of penehyclidine hydrochloride | CHENGDU LIST PHARMACEUTICAL CO LTD | 2014-10-08 | — | — | CN | claimed |
| CN-116046945-B | Method for detecting related substances of penehyclidine hydrochloride injection by high performance liquid chromatography | 上海旭东海普药业有限公司 | 2025-03-11 | — | — | CN | disclosed |
| US-20230167107-A1 | CRYSTALS, PREPARATION METHOD AND APPLICATION OF A MUSCARINIC RECEPTOR ANTAGONIST | BEIJING SHOWBY PHARMACEUTICAL CO., LTD. (CN) | 2023-06-01 | — | — | US | disclosed |
| US-20230167107-A1 | CRYSTALS, PREPARATION METHOD AND APPLICATION OF A MUSCARINIC RECEPTOR ANTAGONIST | BEIJING SHOWBY PHARMACEUTICAL CO., LTD. (CN) | 2023-06-01 | — | — | US | disclosed |
| CN-116046945-A | Method for detecting related substances of penehyclidine hydrochloride injection by high performance liquid chromatography | 上海旭东海普药业有限公司 | 2023-05-02 | — | — | CN | disclosed |
| US-11447485-B2 | Class of bifunctional compounds with quanternary ammonium salt structure | BEIJING SHOWBY PHARMACEUTICAL CO., LTD. (CN) | 2022-09-20 | — | — | US | disclosed |
| CN-110087729-B | Bifunctional compound with quaternary ammonium salt structure | 北京硕佰医药科技有限责任公司 | 2022-04-05 | — | — | CN | disclosed |
| EP-3556435-B1 | CLASS OF BIFUNCTIONAL COMPOUNDS WITH QUATERNARY AMMONIUM SALT STRUCTURE | BEIJING SHOWBY PHARMACEUTICAL CO LTD (CN) | 2020-10-28 | — | — | EP | disclosed |
| EP-3556435-A1 | CLASS OF BIFUNCTIONAL COMPOUNDS WITH QUATERNARY AMMONIUM SALT STRUCTURE | Beijing Showby Pharmaceutical Co., Ltd. (CN) | 2019-10-23 | — | — | EP | disclosed |
| CN-110087729-A | One kind has the dual-function compound of quaternary ammonium salt structure | 北京硕佰医药科技有限责任公司 | 2019-08-02 | — | — | CN | disclosed |
| CN-104090037-B | A kind of detection method of catabolite of amyl ethyl quin ether hydrochloride | CHENGDU LISITE PHARMACEUTICAL CO., LTD. (CN) | 2015-12-30 | — | — | CN | disclosed |
| CN-104090037-B | A kind of detection method of catabolite of amyl ethyl quin ether hydrochloride | CHENGDU LISITE PHARMACEUTICAL CO., LTD. (CN) | 2015-12-30 | — | — | CN | disclosed |
| CN-104090037-A | Detection method of degradation product of penehyclidine hydrochloride | CHENGDU LIST PHARMACEUTICAL CO LTD | 2014-10-08 | — | — | CN | disclosed |
| CN-104090037-A | Detection method of degradation product of penehyclidine hydrochloride | CHENGDU LIST PHARMACEUTICAL CO LTD | 2014-10-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11447485-B2 | Class of bifunctional compounds with quanternary ammonium salt structure | AGTR2, AGTR1, ADRB2 | CHRM2 14/4885CHRM1 15/4885CYP2D6 1087/4885 |
| US-20230167107-A1 | CRYSTALS, PREPARATION METHOD AND APPLICATION OF A MUSCARINIC RECEPTOR ANTAGONIST | CHRM5, CHRM2, CHRM3 | CHRM2 2/4885CHRM1 5/4885CYP2D6 3292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.